Carl Zeiss Meditec AG (AFX) - Total Liabilities

Latest as of September 2025: €1.28 Billion EUR ≈ $1.49 Billion USD

Based on the latest financial reports, Carl Zeiss Meditec AG (AFX) has total liabilities worth €1.28 Billion EUR (≈ $1.49 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AFX net assets growth trend to track the company's year-over-year net asset growth rate.

Carl Zeiss Meditec AG - Total Liabilities Trend (2014–2025)

This chart illustrates how Carl Zeiss Meditec AG's total liabilities have evolved over time, based on quarterly financial data. See Carl Zeiss Meditec AG (AFX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Carl Zeiss Meditec AG Competitors by Total Liabilities

The table below lists competitors of Carl Zeiss Meditec AG ranked by their total liabilities.

Company	Country	Total Liabilities
DXP Enterprises Inc NASDAQ:DXPE	USA	$956.12 Million
Calumet Specialty Products Partners NASDAQ:CLMT	USA	$3.18 Billion
Long Young Electronic (Kunshan) Co. Ltd. A SHE:301389	China	CN¥807.77 Million
Beijing Xinleineng Technology Co Ltd SHE:300593	China	CN¥1.87 Billion
Jiamei Food Packaging Chuzhou Co SHE:002969	China	CN¥1.13 Billion
TriNet Group Inc NYSE:TNET	USA	$3.34 Billion
CETC Energy Joint Stock Co Ltd SHG:600877	China	CN¥463.01 Million
Carborundum Universal Limited NSE:CARBORUNIV	India	Rs11.55 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Carl Zeiss Meditec AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AFX market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Carl Zeiss Meditec AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Carl Zeiss Meditec AG (2014–2025)

The table below shows the annual total liabilities of Carl Zeiss Meditec AG from 2014 to 2025.

Year	Total Liabilities	Change
2025-09-30	€1.28 Billion ≈ $1.49 Billion	-4.57%
2024-09-30	€1.34 Billion ≈ $1.56 Billion	+55.43%
2023-09-30	€860.02 Million ≈ $1.01 Billion	+8.49%
2022-09-30	€792.73 Million ≈ $926.78 Million	+10.32%
2021-09-30	€718.59 Million ≈ $840.10 Million	+27.70%
2020-09-30	€562.73 Million ≈ $657.89 Million	-7.01%
2019-09-30	€605.17 Million ≈ $707.51 Million	+74.19%
2018-09-30	€347.42 Million ≈ $406.17 Million	-8.90%
2017-09-30	€381.37 Million ≈ $445.87 Million	-3.83%
2016-09-30	€396.57 Million ≈ $463.63 Million	+16.01%
2015-09-30	€341.84 Million ≈ $399.65 Million	+19.99%
2014-09-30	€284.88 Million ≈ $333.06 Million	--

About Carl Zeiss Meditec AG

F:AFX Germany Medical Instruments & Supplies

Market Cap

$2.98 Billion

€2.55 Billion EUR

Market Cap Rank

#5813 Global

#900 in Germany

Share Price

€29.16

Change (1 day)

-6.96%

52-Week Range

€23.34 - €47.76

All Time High

€196.24